webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

H-D-Tyr(Propargyl)-OH

  CAS No.: 1170674-20-0   Cat No.: BADC-01716 4.5  

H-D-Tyr(Propargyl)-OH is a propargyl-modified tyrosine ADC linker component facilitating copper-catalyzed click chemistry for efficient payload conjugation in antibody-drug conjugates. It ensures stability and specificity, enhancing targeted drug delivery. Keywords: ADC linker, propargyl linker, tyrosine derivative, click chemistry, payload conjugation.

H-D-Tyr(Propargyl)-OH

Structure of 1170674-20-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C12H13NO3
Molecular Weight
219.24

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
O-Propargyl-D-tyrosine; (r)-2-amino-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid
IUPAC Name
(2R)-2-amino-3-(4-prop-2-ynoxyphenyl)propanoic acid
Canonical SMILES
C#CCOC1=CC=C(C=C1)CC(C(=O)O)N
InChI
InChI=1S/C12H13NO3/c1-2-7-16-10-5-3-9(4-6-10)8-11(13)12(14)15/h1,3-6,11H,7-8,13H2,(H,14,15)/t11-/m1/s1
InChIKey
JSXMFBNJRFXRCX-LLVKDONJSA-N

H-D-Tyr(Propargyl)-OH is a modified amino acid consisting of tyrosine (Tyr) with a propargyl group attached to its side chain. The propargyl group is an alkyne functional group that plays a critical role in bioorthogonal chemistry, particularly in click chemistry applications. This modification allows for selective reactions with azide-functionalized molecules, facilitating the formation of stable covalent bonds without interference from other biological processes. Due to these properties, H-D-Tyr(Propargyl)-OH is often used as a key building block in the synthesis of bioconjugates, such as peptide-drug conjugates (PDCs), for targeted therapy, and in the development of molecular probes for diagnostics.

One of the primary applications of H-D-Tyr(Propargyl)-OH is in the field of targeted drug delivery. The propargyl group allows for efficient and specific conjugation to other biomolecules via click chemistry reactions, such as coupling to azide-tagged therapeutic agents or peptides. This makes H-D-Tyr(Propargyl)-OH ideal for creating peptide-drug conjugates (PDCs), which are designed to deliver cytotoxic drugs selectively to cancer cells, minimizing off-target effects and systemic toxicity. The tyrosine residue, with its aromatic side chain, also provides potential for interactions with specific receptors or enzymes, further enhancing the targeting capability of these conjugates. This application holds significant promise for improving the precision of cancer therapies and other diseases requiring targeted drug delivery.

In addition to its role in drug delivery, H-D-Tyr(Propargyl)-OH is used in chemical biology and proteomics. The propargyl group enables the selective labeling of proteins, peptides, or other biomolecules, allowing researchers to track and study molecular interactions in living systems. The compound can be conjugated with azide-functionalized imaging agents or fluorescent probes for use in live-cell imaging, providing valuable insights into cellular processes such as receptor binding, protein trafficking, and enzymatic activity. This capability is particularly important for understanding disease mechanisms, identifying new therapeutic targets, and discovering biomarkers for early disease detection.

H-D-Tyr(Propargyl)-OH also finds applications in the development of biomaterials and surface functionalization. By incorporating the propargyl group into peptide-based materials or coatings, researchers can use click chemistry to selectively attach functional molecules to surfaces, such as growth factors, antibodies, or enzymes. This is useful in tissue engineering and regenerative medicine, where functionalized biomaterials are required to promote cell adhesion, tissue regeneration, or wound healing. The tyrosine residue enhances the interaction with biomolecules and can also participate in further modifications to tailor the material properties for specific applications.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 1-Boc-azetidine-3-yl-methanol | 11-Azidoundecanoic acid | Mal-PEG4-PFP | Azide-C2-SS-C2-biotin | 4-Maleimidobutyric acid | MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH | Boc-L-Tyr(2-azidoethyl)-OH | Dov-Val-Dil-OH TFA | Dov-Val-Dil-OH | H-L-Lys(N3-Gly)-OH | H-D-Tyr(Propargyl)-OH
Send Inquiry
Verification code
Inquiry Basket